Literature DB >> 21420030

Involvement of microRNAs in lung cancer biology and therapy.

Xi Liu1, Lorenzo F Sempere, Yongli Guo, Murray Korc, Sakari Kauppinen, Sarah J Freemantle, Ethan Dmitrovsky.   

Abstract

MicroRNAs (miRNAs) are a class of small RNAs that regulate gene expression. Expression profiles of specific miRNAs have improved cancer diagnosis and classification as well as provided prognostic information in many human cancers, including lung cancer. Tumor-suppressive and oncogenic miRNAs were uncovered in lung carcinogenesis. The biological functions of these miRNAs in lung cancer were validated recently in well-characterized cellular, murine transgenic as well as transplantable lung cancer models, and in human paired normal-malignant lung tissue banks and tissue arrays. Tumor-suppressive and oncogenic miRNAs that were identified in lung cancer will be reviewed here. Emphasis is placed on highlighting those functionally validated miRNAs that are not only biomarkers of lung carcinogenesis but also candidate pharmacologic targets. How these miRNA findings advance an understanding of lung cancer biology and how they could improve lung cancer therapy are discussed in this article.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420030      PMCID: PMC3072599          DOI: 10.1016/j.trsl.2011.01.001

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  77 in total

1.  The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene.

Authors:  Yi Wen Kong; Ian G Cannell; Cornelia H de Moor; Kirsti Hill; Paul G Garside; Tiffany L Hamilton; Hedda A Meijer; Helen C Dobbyn; Mark Stoneley; Keith A Spriggs; Anne E Willis; Martin Bushell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

2.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

3.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

4.  MicroRNA signature predicts survival and relapse in lung cancer.

Authors:  Sung-Liang Yu; Hsuan-Yu Chen; Gee-Chen Chang; Chih-Yi Chen; Huei-Wen Chen; Sher Singh; Chiou-Ling Cheng; Chong-Jen Yu; Yung-Chie Lee; Han-Shiang Chen; Te-Jen Su; Ching-Cheng Chiang; Han-Ni Li; Qi-Sheng Hong; Hsin-Yuan Su; Chun-Chieh Chen; Wan-Jiun Chen; Chun-Chi Liu; Wing-Kai Chan; Wei J Chen; Ker-Chau Li; Jeremy J W Chen; Pan-Chyr Yang
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

5.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

6.  Widespread microRNA repression by Myc contributes to tumorigenesis.

Authors:  Tsung-Cheng Chang; Duonan Yu; Yun-Sil Lee; Erik A Wentzel; Dan E Arking; Kristin M West; Chi V Dang; Andrei Thomas-Tikhonenko; Joshua T Mendell
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

7.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

Authors:  I A Asangani; S A K Rasheed; D A Nikolova; J H Leupold; N H Colburn; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

8.  Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.

Authors:  Fang Sun; Hanjiang Fu; Qin Liu; Yi Tie; Jie Zhu; Ruiyun Xing; Zhixian Sun; Xiaofei Zheng
Journal:  FEBS Lett       Date:  2008-04-10       Impact factor: 4.124

9.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene.

Authors:  Z Lu; M Liu; V Stribinskis; C M Klinge; K S Ramos; N H Colburn; Y Li
Journal:  Oncogene       Date:  2008-03-31       Impact factor: 9.867

10.  Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.

Authors:  Joacim Elmén; Morten Lindow; Asli Silahtaroglu; Mads Bak; Mette Christensen; Allan Lind-Thomsen; Maj Hedtjärn; Jens Bo Hansen; Henrik Frydenlund Hansen; Ellen Marie Straarup; Keith McCullagh; Phil Kearney; Sakari Kauppinen
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  16 in total

1.  MicroRNAs: miRRORS of health and disease.

Authors:  Monty Montano
Journal:  Transl Res       Date:  2011-02-11       Impact factor: 7.012

Review 2.  Role of MicroRNAs in lung disease.

Authors:  Martín Angulo; Emilia Lecuona; Jacob Iasha Sznajder
Journal:  Arch Bronconeumol       Date:  2012-05-17       Impact factor: 4.872

Review 3.  MicroRNA-21 gene and cancer.

Authors:  Yong Huang; You Bing Yang; Xiao Hui Zhang; Xue Li Yu; Zhan Bin Wang; Xiang Chao Cheng
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

4.  Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway.

Authors:  Jun He; Xu Qian; Richard Carpenter; Qing Xu; Lin Wang; Yanting Qi; Zi-Xuan Wang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Toxicol Sci       Date:  2013-06-07       Impact factor: 4.849

Review 5.  Epigenetic mechanisms in commonly occurring cancers.

Authors:  Lauren P Blair; Qin Yan
Journal:  DNA Cell Biol       Date:  2012-04-20       Impact factor: 3.311

6.  Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation.

Authors:  Olga Surova; Nadeem Shahzad Akbar; Boris Zhivotovsky
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

7.  Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.

Authors:  Carina Roth; Isabel Stückrath; Klaus Pantel; Jakob R Izbicki; Michael Tachezy; Heidi Schwarzenbach
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

8.  PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells.

Authors:  Chen Zhang; Yuanzhuo Chen; Mingsong Wang; Xianzhen Chen; Yongxin Li; E Song; Xiaoqing Liu; Sekwon Kim; Hu Peng
Journal:  World J Surg Oncol       Date:  2014-08-13       Impact factor: 2.754

Review 9.  Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?

Authors:  Lorenzo F Sempere
Journal:  Expert Rev Mol Diagn       Date:  2014-08-04       Impact factor: 5.225

10.  Proteogenomics of selective susceptibility to endotoxin using circulating acute phase biomarkers and bioassay development in sheep: a review.

Authors:  Saul Chemonges; John-Paul Tung; John F Fraser
Journal:  Proteome Sci       Date:  2014-03-01       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.